Conductive Keratoplasty From Advance VisionCare

Technology

First FDA Approved Technology for Presbyopic Patients

Advance VisionCare use the very latest technology for the Conductive Keratoplasty (CK) procedure. The ViewPoint® CK System from Refractec is used and is the first FDA-approved refractive technology for improving the loss of near vision that accompanies presbyopia. The new LightTouch technique from Refractec reduces the compression to a minimum which produces more stable and predictable results.

The NearVision CK treatment has one of the highest safety profiles in the refractive market thanks to the use of radio waves, instead of a laser or scalpel, that gently change the shape of the cornea to improve vision.

How It Works

NearVision CK applies radio waves in a circular pattern on the outer cornea to shrink small areas of collagen.It is applied using a probe thinner than a human hair. This shrinking pattern creates a constrictive band (like the tightening of a belt) increasing the overall curvature of the cornea to bring near vision back into focus.

When the cornea is compressed, it causes a mechanical stretching effect on the corneal fibres that resists the natural tendency of the tissue being drawn toward the pulse of RF energy.

Using the LightTouch technique, the amount of compression is greatly reduced or eliminated.

In preliminary findings, this low-compression technique may produce more robust results by minimizing the corneal stretching associated with the standard CK technique.

The technology used during the procedure was engineered and designed specifically for performing Conductive Keratoplasty.

This means that the precise amount of radiowave energy needed to affect the corneal tissue, at the precise tissue temperature and depth of treatment, were meticulously investigated and defined. The Keratoplast Tip penetrates the cornea to a depth of 450 µm and utilizes a stop at the very distal portion to assure precise depth of penetration.